Elan Corporation

Pharmaceutical company

1/6/2009 02:44 ET

Site Map | Contact Us | Search:

  • NYSE | ELN | 7.19 | +0.41  (20 minute delay)
   

 

 


               These are large files please allow sufficient time to download

Feature:

  • Elan to Present at the 27th Annual JP Morgan Healthcare Conference...more
  • Elan Announces Resource Realignment...more
  • John Moriarty Joins Elan as SVP, Legal—Commercial Operations & Litigation...more
  • Mary Stutts to Join Elan as Senior Vice President and Head of Corporate Relations...more  

Marketed Products
in the U.S.

  • TYSABRI®
    (natalizumab)
  • PRIALT®
    (ziconotide intrathecal infusion) 
  • Azactam®
    (aztreonam for injection, USP)
  • Maxipime®
    (cefepime hydrochloride) for injection                      

Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use